517 related articles for article (PubMed ID: 21586182)
21. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains.
Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M
Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614
[TBL] [Abstract][Full Text] [Related]
22. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits.
Johnson AE; Jeppsson F; Sandell J; Wensbo D; Neelissen JA; Juréus A; Ström P; Norman H; Farde L; Svensson SP
J Neurochem; 2009 Mar; 108(5):1177-86. PubMed ID: 19141073
[TBL] [Abstract][Full Text] [Related]
23. Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients.
Kung MP; Skovronsky DM; Hou C; Zhuang ZP; Gur TL; Zhang B; Trojanowski JQ; Lee VM; Kung HF
J Mol Neurosci; 2003 Feb; 20(1):15-24. PubMed ID: 12663930
[TBL] [Abstract][Full Text] [Related]
24. Amyloid PET Imaging: Standardization and Integration with Other Alzheimer's Disease Biomarkers.
Morbelli S; Bauckneht M
Methods Mol Biol; 2018; 1750():203-212. PubMed ID: 29512074
[TBL] [Abstract][Full Text] [Related]
25. Advances in Aβ plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease.
Jovalekic A; Bullich S; Catafau A; de Santi S
Neurodegener Dis Manag; 2016 Dec; 6(6):491-497. PubMed ID: 27813444
[TBL] [Abstract][Full Text] [Related]
26. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
[TBL] [Abstract][Full Text] [Related]
27. 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease.
Calamai E; Dall'Angelo S; Koss D; Domarkas J; McCarthy TJ; Mingarelli M; Riedel G; Schweiger LF; Welch A; Platt B; Zanda M
Chem Commun (Camb); 2013 Jan; 49(8):792-4. PubMed ID: 23235438
[TBL] [Abstract][Full Text] [Related]
28. Validation of an (18)F-labeled biphenylalkyne as a positron emission tomography imaging agent for beta-amyloid plaques.
Wey SP; Weng CC; Lin KJ; Yao CH; Yen TC; Kung HF; Skovronsky D; Kung MP
Nucl Med Biol; 2009 May; 36(4):411-7. PubMed ID: 19423009
[TBL] [Abstract][Full Text] [Related]
29. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
30. Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia.
Thal DR; Ronisz A; Tousseyn T; Rijal Upadhaya A; Balakrishnan K; Vandenberghe R; Vandenbulcke M; von Arnim CAF; Otto M; Beach TG; Lilja J; Heurling K; Chakrabarty A; Ismail A; Buckley C; Smith APL; Kumar S; Farrar G; Walter J
Acta Neuropathol Commun; 2019 Nov; 7(1):178. PubMed ID: 31727169
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of a (18)F-curcumin derivate for β-amyloid plaque imaging.
Rokka J; Snellman A; Zona C; La Ferla B; Nicotra F; Salmona M; Forloni G; Haaparanta-Solin M; Rinne JO; Solin O
Bioorg Med Chem; 2014 May; 22(9):2753-62. PubMed ID: 24702859
[TBL] [Abstract][Full Text] [Related]
32. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease.
Shin J; Lee SY; Kim SH; Kim YB; Cho SJ
Neuroimage; 2008 Nov; 43(2):236-44. PubMed ID: 18694837
[TBL] [Abstract][Full Text] [Related]
33. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
34. PET imaging of amyloid in Alzheimer's disease.
Nordberg A
Lancet Neurol; 2004 Sep; 3(9):519-27. PubMed ID: 15324720
[TBL] [Abstract][Full Text] [Related]
35. [Molecular imaging of beta-amyloid plaques in the brain].
Ono M
Brain Nerve; 2007 Mar; 59(3):233-40. PubMed ID: 17370649
[TBL] [Abstract][Full Text] [Related]
36. [The contribution of nuclear medicine procedures in the diagnosis of dementia of Alzheimer's type. Imaging beta amyloid plaques].
Tsolaki M; Trontzos C; Kazis A
Hell J Nucl Med; 2005; 8(3):187-90. PubMed ID: 16390030
[TBL] [Abstract][Full Text] [Related]
37. Development of [
Reddy TT; Iguban MH; Melkonyan LL; Shergill J; Liang C; Mukherjee J
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677925
[TBL] [Abstract][Full Text] [Related]
38. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease.
Chen CD; Joseph-Mathurin N; Sinha N; Zhou A; Li Y; Friedrichsen K; McCullough A; Franklin EE; Hornbeck R; Gordon B; Sharma V; Cruchaga C; Goate A; Karch C; McDade E; Xiong C; Bateman RJ; Ghetti B; Ringman JM; Chhatwal J; Masters CL; McLean C; Lashley T; Su Y; Koeppe R; Jack C; Klunk WE; Morris JC; Perrin RJ; Cairns NJ; Benzinger TLS
Acta Neuropathol; 2021 Oct; 142(4):689-706. PubMed ID: 34319442
[TBL] [Abstract][Full Text] [Related]
39. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
40. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
Wolk DA; Zhang Z; Boudhar S; Clark CM; Pontecorvo MJ; Arnold SE
J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):923-6. PubMed ID: 22791901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]